1. Home
  2. NTLA vs NWN Comparison

NTLA vs NWN Comparison

Compare NTLA & NWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intellia Therapeutics Inc.

NTLA

Intellia Therapeutics Inc.

N/A

Current Price

$12.72

Market Cap

1.8B

Sector

Health Care

ML Signal

N/A

Logo Northwest Natural Holding Company

NWN

Northwest Natural Holding Company

N/A

Current Price

$49.25

Market Cap

2.1B

Sector

Utilities

ML Signal

N/A

Company Overview

Basic Information
Metric
NTLA
NWN
Founded
2014
1859
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Oil/Gas Transmission
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
2.1B
IPO Year
2016
2018

Fundamental Metrics

Financial Performance
Metric
NTLA
NWN
Price
$12.72
$49.25
Analyst Decision
Buy
Buy
Analyst Count
23
3
Target Price
$20.02
$54.33
AVG Volume (30 Days)
3.1M
178.8K
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
3.71%
EPS Growth
27.43
36.45
EPS
N/A
2.33
Revenue
$67,671,000.00
$1,289,363,000.00
Revenue This Year
N/A
$11.37
Revenue Next Year
$62.75
$4.46
P/E Ratio
N/A
$21.23
Revenue Growth
16.92
11.83
52 Week Low
$7.95
$40.90
52 Week High
$28.24
$55.99

Technical Indicators

Market Signals
Indicator
NTLA
NWN
Relative Strength Index (RSI) 51.41 45.73
Support Level $12.55 $48.33
Resistance Level $13.88 $49.63
Average True Range (ATR) 0.66 0.84
MACD 0.06 -0.10
Stochastic Oscillator 53.28 25.52

Price Performance

Historical Comparison
NTLA
NWN

About NTLA Intellia Therapeutics Inc.

Intellia Therapeutics is a gene-editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

About NWN Northwest Natural Holding Company

Northwest Natural Holding Co is a public natural gas service supplier operating in the U.S. Pacific Northwest. Its subsidiary, NW Natural, operates through the natural gas distribution segment, which purchases and distributes natural gas through which operates in Oregon and southwest Washington. The company operates in three reportable business segments, which are NWN Gas Utility, SiEnergy, and NWN Water. The company generates maximum revenue from NWN Gas Utility segment. It also generates revenue from residential, commercial, and industrial customers, the majority of which are in Oregon. Residential and commercial customers account for the vast majority of profitability.

Share on Social Networks: